Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Front page image of the Sustainable Development Impact Summit 2021

Professor Ilina Singh, Department of Psychiatry, University of Oxford, took part in the recent Sustainable Development Impact Summit 2021, where she led a session entitled, Meet the Pioneers tackling the Mental Health Crisis.

From March 2020 onwards, prevalence of anxiety and depression increased and in some countries even doubled. However, COVID-19 has also accelerated digital innovations, especially in telemedicine. What does it take to scale innovations that help end the mental health crisis?

The Sustainability Pioneers series showcases entrepreneurs and innovators tackling today's major challenges to achieve the Sustainable Development Goals.

Watch the full discussion with Ilina Singh, Lisa McLaughlin, and Robin McIntosh.

 

Professor Singh, said:

 

'We live in a world that faces years of recovery from COVID-19, a process that continues to highlight pre-existing health and structural inequalities among nations and citizens. Against this background, the World Economic Forum Sustainable Development Impact Summit rightly focuses on the huge challenge of achieving the WHO Sustainable Development Goals (SDGs) with less than a decade to go. Mental health and wellbeing was already high on the WHO agenda, with SDGs focused on health, youth and workplace; now it is also one the major long-term consequences of the pandemic.

'I was really pleased to participate in the Sustainable Pioneers programme, which featured the development of innovative digital technologies to expand the reach of mental health interventions, and to improve trust and acceptability of treatment for highly stigmatised conditions.'

For more information visit the World Economic Forum.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

What is the Role of Science in Mental Health?

A new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.

New Research Presented at the ECNP Conference - October 2021

Dr Angharad de Cates and Dr Liliana Capitão were just two of the department's researchers presenting and publishing new research at the European College of Neuropsychopharmacology (ECNP) Conference 2021, in Lisbon.

Researchers Address Mental Health Effects of the Pandemic on Young People

In a new policy briefing, a team of researchers at King’s College London and Oxford University highlight the multiple effects that the COVID-19 pandemic has had on children and young people in the UK through their education and daily life, including challenges around social isolation, academic pressures, adjusting to online learning and coping with reopening of schools.

Turing Fellowships for Over 30 Oxford Academics

Professor John Geddes, WA Handley-elect Chair of Psychiatry, is one of the thirty-three University of Oxford researchers, which have been named Turing Fellows for the 2021/22 academic year.

Simple Intervention Effectively Treats Depression During COVID 19

New research shows that even a very simple intervention, administered by non-specialists with just 15 hours of training, can effectively treat depression during COVID-19.

Over a Third of COVID-19 Patients Diagnosed with at Least One Long-COVID Symptom

A new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.